Grifols | GRFS - Trade Debtors


Grifols reported EUR1B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Alaunos Therapeutics USD 2K 0 Jun/2025
aTyr Pharma USD 296.74M 295.7M Dec/2025
Brainstorm Cell Therapeutics USD 86K 6K Dec/2025
Capricor Therapeutics USD 59K 0 Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Grifols EUR 1B 285.88M Dec/2025
Immunic USD 1.5M 50K Jun/2024
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
TherapeuticsMD USD 2.91M 310K Jun/2024